Stefania Morino

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Comparative Study of Sporadic and Immune Checkpoint Inhibitor-Related Forms of Myasthenia Gravis-Myositis Overlap Syndrome.

Comparative Study of Sporadic and Immune Checkpoint Inhibitor-Related Forms of Myasthenia Gravis-Myositis Overlap Syndrome.

Journal: Neurology

Published: May 26, 2026

Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study.

Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study.

Journal: Journal of the neurological sciences

Published: October 06, 2025

Sporadic late-onset nemaline myopathy (SLONM): Data from a case series and literature review of 144 patients.

Sporadic late-onset nemaline myopathy (SLONM): Data from a case series and literature review of 144 patients.

Journal: Autoimmunity reviews

Published: August 06, 2025

Immunological Targets in Generalized Myasthenia Gravis Treatment: Where Are We Going Now?

Immunological Targets in Generalized Myasthenia Gravis Treatment: Where Are We Going Now?

Journal: Brain sciences

Published: July 18, 2025

Response to letter to the editor: "Emergent role of complement inhibitors in myasthenic crisis" (CNN-D-25-2224).

Response to letter to the editor: "Emergent role of complement inhibitors in myasthenic crisis" (CNN-D-25-2224).

Journal: Clinical neurology and neurosurgery

Published: July 17, 2025

Response to comment on: "Emergent role of complement inhibitors in myasthenic crisis - Complement for crisis, FcRn for continuity (CNN-D-25-2177)".

Response to comment on: "Emergent role of complement inhibitors in myasthenic crisis - Complement for crisis, FcRn for continuity (CNN-D-25-2177)".

Journal: Clinical neurology and neurosurgery

Published: July 17, 2025

Diagnostic Performance of Three Serological Assays in Myasthenia Gravis: A Prospective Multicentre Study.

Diagnostic Performance of Three Serological Assays in Myasthenia Gravis: A Prospective Multicentre Study.

Journal: Scandinavian journal of immunology

Published: May 11, 2025

Emergent role of complement inhibitors in myasthenic crisis: Understanding why, when and how.

Emergent role of complement inhibitors in myasthenic crisis: Understanding why, when and how.

Journal: Clinical neurology and neurosurgery

Published: March 28, 2025

Ravulizumab for generalized Myasthenia Gravis: a multicenter real-life experience.

Ravulizumab for generalized Myasthenia Gravis: a multicenter real-life experience.

Journal: Journal of neurology

Published: March 12, 2025

Correction: Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study.

Correction: Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study.

Journal: Journal of neurology

Published: February 01, 2025

Muscle hypertrophy following acquired neurogenic injury: systematic review and analysis of existing literature.

Muscle hypertrophy following acquired neurogenic injury: systematic review and analysis of existing literature.

Journal: Annals of clinical and translational neurology

Published: April 10, 2024

Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN).

Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN).

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: March 18, 2024

Showing 1-12 of 35

Last Updated: 09/26/2026